rethinkTHC Search
Menu
Study breakdown

CBD shows potential as an add-on treatment for managing opioid withdrawal symptoms

ReviewPreliminary evidence
The takeaway

A review found that CBD has anxiolytic, anti-inflammatory, analgesic, anti-emetic, and craving-reducing properties relevant to opioid withdrawal, and is well tolerated even alongside opioid agonists, but clinical evidence remains limited.

Addiction medicine specialists, detoxification program clinicians, and researchers designing opioid withdrawal treatment trials.

CBD addresses anxiety, pain, nausea, and cravings; safe with opioids

What the researchers found

CBD has been reported to have anxiolytic, antidepressant, anti-inflammatory, anti-emetic, and analgesic properties, plus reduction of cue-induced craving for opioids, all highly relevant to withdrawal symptoms. CBD is well tolerated with no significant adverse effects even when co-administered with potent opioid agonists.

Why it matters

Opioid withdrawal management remains a critical challenge. Insufficient withdrawal treatment leads to relapse and overdose. CBD as a non-addictive adjunctive treatment could fill an unmet need.

The numbers in context

144 abstracts identified, 41 articles selected. CBD properties relevant to withdrawal: anxiolytic, antidepressant, anti-inflammatory, anti-emetic, analgesic, craving reduction. Well tolerated with opioid co-administration.

How the study worked

Literature review using PubMed and Google Scholar for keywords related to CBD and opioid withdrawal. 144 abstracts identified, 41 articles selected where CBD was evaluated in clinical studies relevant to opioid withdrawal.

What this study cannot tell us

Most evidence from preclinical studies and small clinical trials. No large randomized controlled trials of CBD specifically for opioid withdrawal. Optimal dosing, timing, and duration unknown.

How to read the evidence

Review of 41 relevant articles but most evidence is preclinical or from small clinical studies.

When this study was published

Published in 2022.

The bigger picture

If CBD can address multiple withdrawal symptoms simultaneously (anxiety, pain, nausea, cravings) with minimal side effects, it could be a uniquely useful adjunct to standard detoxification protocols.

Questions still open

  • What is the optimal CBD dose for opioid withdrawal management? Would CBD reduce the need for other withdrawal medications? Could CBD facilitate transition to maintenance medications?

Common questions

Can CBD help with opioid withdrawal?
CBD has properties (anti-anxiety, pain relief, anti-nausea, craving reduction) that align with opioid withdrawal symptoms, and it appears safe alongside opioids. However, large clinical trials are still needed.
Is it safe to take CBD while on opioids?
Several clinical trials reported in this review found CBD to be well tolerated with no significant adverse effects when co-administered with potent opioid agonists.

Read the original research

Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.

Cannabis and cannabinoid research, 7(5), 569-581

Citation

Kudrich, Christopher; Hurd, Yasmin L; Salsitz, Edwin; Wang, An-Li. (2022). Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.. Cannabis and cannabinoid research, 7(5), 569-581. https://doi.org/10.1089/can.2021.0089

Explore the wider topic